Med Parmasi Group (შპს მედ ფარმასი გრუპი) — Georgia Financials

Georgia Financials

panel 2026-09-21Ask

Med Parmasi Group (შპს მედ ფარმასი გრუპი) — Georgia Financials

as filed · GEL, thousands

Line item	2018	2019	2020	2021	2022	2023	2024	CAGR
Total Revenue	1,824	1,645	2,094	2,610	2,282	1,474	1,185	-6.9%
Total COGS	1,180	1,070	1,209	1,537	1,172	873	752	-7.2%
Gross Profit	644	575	886	1,073	1,109	601	433	-6.4%
Gross Margin	35.3%	35.0%	42.3%	41.1%	48.6%	40.8%	36.5%
	318	340	410	858	1,039	1,166	444	+5.7%
EBITDA	326	235	476	214	70	565	11	nmf
EBITDA Margin	17.8%	14.3%	22.7%	8.2%	3.1%	38.3%	0.9%
Total D&A	27	28	30	54	52	61	61	+14.3%
EBIT / Operating Income	298	206	446	160	18	626	72	nmf
Total Interest Expense	29	41	26	13	3	0	0	nmf
Total Other Income	0	3	0	14	30	15	32	+62.2%
Profit Before Tax	269	163	420	133	15	641	105	nmf
Total Income Tax	40	24	63	20	0	0	0	-20.9%
Net Profit / (Loss)	229	139	357	113	13	582	48	nmf
Net Margin	12.5%	8.4%	17.1%	4.3%	0.6%	39.5%	4.1%